Five Reasons Why Diversity Matters in Clinical Trials

What is CIDP? This commonly misdiagnosed disease is associated with weakness, numbness and tingling in the arms and legs.

Our CEO Talks About Pandemic Learnings: Vaccines, Business Confidence and Innovation

Participation in a Virtual Australian Event

Popular search terms:

COVID-19: A Message from Our CEO

"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited

Read More About CSL Behring's Efforts with COVID-19

The Next Wave of Olympic Dreams

For the first time, surfing joins the lineup of Olympic sports in this year’s delayed, pandemic-burdened Japan summer games. …

23 Jul 2021

silhouette of woman in an airport with luggage

Our No. 1 Travel Tip

Taking medications with you on a flight? Don’t take off without hearing this piece of advice from our associate director of m…

22 Jul 2021

Wellness: Three At-Home Workouts

Boost your physical and mental health with three convenient workouts that can be done from anywhere.

21 Jul 2021

A Green Belt in Efficiency

With Six Sigma training, a CSL Plasma team designs processes that solve problems and reduce waste.

20 Jul 2021

a group of young and old patients holding a Stronger Together sign

5 Reasons Why Diversity Matters in Clinical Trials

Broadening access to clinical trials is better for science and patients.

19 Jul 2021

illustrations of tangled thoughts unraveling

Five Tips for Managing Mental Health

In year two of a pandemic, take care of yourself and create a healthy work environment for others, experts say.

16 Jul 2021

Research Aimed at the Sickest COVID-19 Patients

Dr. William Zhang receives the American Thoracic Society/CSL Behring Research Award to study Acute Respiratory Distress Syndr…

15 Jul 2021

CSL Limited CEO Paul Perreault records a video for employees in the King of Prussia, Pennsylvania studio.

Ready to Return to Working On-Sites

Ahead of all employees soon returning to working on-sites, CSL CEO Paul Perreault puts in time at the company’s Pennsylvania …

14 Jul 2021

Bill Mezzanotte, CSL Chief Medical Officer and Head of R&D

Together, Let's Move at the Speed of Science

A condensed version of my address to academia, governments and industry during the Times Higher Education Health and Wellbein…

13 Jul 2021

Our Focus on Serious & Rare Diseases

Our portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies, and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency.